Speakers

Ash Kras is a retina specialist, Fulbright scholar and Harvard-trained bioinformatician specialized in interoperability and clinical AI. He is also the founder and CEO of…

Gordon Bethwaite is a seasoned ophthalmic industry executive with more than 20 years of global leadership across commercial stage companies and major players in vision…

Evert “Eef” Schimmelpennink has served as LENZ’s President and Chief Executive Officer and a member of the LENZ board of directors since March 2021. Previously,…

Reza Safaei, MD, serves as Vice President and Head of Medical Affairs International at Apellis Pharmaceuticals, where he leads global medical strategy across key therapeutic…

Kim Smith is Founder and CIO of Ausangate Capital, a variable-net biotechnology-focused hedge fund. She has a combined 20 years of experience in various healthcare…

Dr. Vinit Mahajan is a Professor of Ophthalmology at Stanford University and an internationally recognized vitreoretinal surgeon-scientist. He directs the NIH-funded Molecular Surgery and Omics…

Alex Lopez, Chief Commercial Officer for Ace Vision Group, boasts over two decades of leadership and commercial experience in ophthalmology and aesthetics markets. Renowned for…

Biren Amin is a managing director and senior research analyst on the healthcare equity research team covering biotechnology companies. Prior to joining Piper Sandler, Amin…

D. Michael Ackermann is the founder and CEO of Osanni Bio. In addition, he serves as Director of Biotechnology for the Stanford University Byers Center…

Anne Hanneken, M.D., is an Associate Professor of Translational Medicine at the Scripps Research Institute in La Jolla, CA, an active vitreoretinal surgeon at Scripps…

Ben Toker | Co-Founder, CTO, Amaros Ben Toker is a serial entrepreneur and technologist with strong commercial acumen and a focus on digital health. He…

Wayne Caulder recently joined Bausch + Lomb in July 2025 as Vice President & General Manager, Surgical for the U.S. and Canada. With over 30…